{
  "basic_data": [
    {
      "cell_line_alt_name": "SPG2-S376C1",
      "cell_type": "iPSC",
      "frozen": "True",
      "hpscreg_name": "AIBNi016-A"
    }
  ],
  "generator": [
    {
      "group": "Australian Institute for Bioengineering and Nanotechnology"
    }
  ],
  "contact": [
    {
      "first_name": "Ernst",
      "name_initials": "J",
      "e_mail": "e.wolvetang@uq.edu.au",
      "last_name": "Wolvetang",
      "group": "Wolvetang-AIBN"
    }
  ],
  "publications": [
    {
      "last_author": "Ernst J. Wolvetang",
      "year": "2022.0",
      "first_author": "Hannah C. Leeson",
      "doi": "10.1016/j.scr.2022.102917",
      "journal": "Stem Cell Research",
      "title": "Generation of iPSC lines from hereditary spastic paraplegia 56 (SPG56) patients and family members carrying CYP2U1 mutations"
    }
  ],
  "donor": [
    {
      "sex": "Female",
      "age": "A1_4",
      "disease_description": "CYP2U1 compound heterozygous mutations (Exon 1 deletion c.471delC; p.(Ile158fs) and Exon 2 substitution c.1085T>C; p.(Leu362Pro))",
      "disease_name": "Hereditary spastic paraplegia 56 (SPG56)"
    }
  ],
  "genomic_modifications": [
    {
      "description": "Compound heterozygous CYP2U1 variants: Exon 1 deletion c.471delC; p.(Ile158fs) and Exon 2 substitution c.1085T>C; p.(Leu362Pro). These are patient-derived variants, not engineered.",
      "loci_name": "CYP2U1",
      "genotype": "c.471delC; p.(Ile158fs); c.1085T>C; p.(Leu362Pro)",
      "mutation_type": "VA"
    }
  ],
  "differentiation_results": [
    {
      "description": "in vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "EN",
      "marker_list": "FOXA2; SOX17; CXCR4",
      "method_used": "qPCR"
    },
    {
      "description": "in vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "ME",
      "marker_list": "PDGFRA; HAND1; BMP4; RUNX1",
      "method_used": "qPCR"
    },
    {
      "description": "in vitro directed differentiation",
      "show_potency": "True",
      "cell_type": "EC",
      "marker_list": "OTX2; PAX6; NR2F2; VIMENTIN",
      "method_used": "qPCR"
    }
  ],
  "genomic_characterisation": [
    {
      "passage_number": "16",
      "karyotype": "Normal karyotype reported across lines (no large-scale chromosomal abnormalities detected)",
      "summary": "SNP array (Illumina HumanCytoSNP-12, ~300,000 markers) conducted (passage 16) showed normal karyotypes across lines. STR analysis (10 loci) matched donor cells; SNP array used to assess unbalanced chromosomal aberrations.",
      "karyotype_method": "MKSNP"
    }
  ],
  "induced_derivation": [
    {
      "i_source_cell_origin_term": "blood",
      "derivation_year": "2021",
      "non_int_vector_name": "CytoTune 2.0 Sendai Virus Kit (ThermoFisher Scientific)",
      "i_source_cell_type_term": "Peripheral Blood Mononuclear Cells (PBMCs)",
      "non_int_vector": "Sendai virus"
    }
  ],
  "ethics": [
    {
      "institutional_HREC": "UQ HREC",
      "ethics_number": "UQ HREC 2,019,000,159"
    }
  ],
  "culture_medium": [
    {
      "co2_concentration": "0.05",
      "passage_method": "EN"
    }
  ]
}